Northwest Biotherapeutics, Inc.
OTC:NWBO
0.82315 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.932 | 1.683 | 1.005 | 1.291 | 2.41 | 0.412 | 0.336 | 0.623 | 1.739 | 1.454 | 0.809 | 0.772 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.8 | 0.124 | 0.39 | 0.529 | 0.009 | 0.129 | 0.156 | 0.21 | 0.39 | 0.48 | 0.23 |
Cost of Revenue
| 27.73 | 1.548 | 20.308 | 33.637 | 14.106 | 18.154 | 33.515 | 60.081 | 103.12 | 85.637 | 43.906 | 28.908 | 0 | 0 | 0 | 0 | 0.012 | 0.01 | 0.012 | 0.04 | 0.079 | 0.007 | 0.067 | 0.051 | 0.05 | 0.08 | 0 | 0 |
Gross Profit
| -25.798 | 0.135 | -19.303 | -32.346 | -11.696 | -17.742 | -33.179 | -59.458 | -101.381 | -84.183 | -43.097 | -28.136 | 0.01 | 0.01 | 0.01 | 0.01 | -0.002 | 0.79 | 0.112 | 0.35 | 0.45 | 0.002 | 0.063 | 0.105 | 0.16 | 0.31 | 0.48 | 0.23 |
Gross Profit Ratio
| -13.353 | 0.08 | -19.207 | -25.055 | -4.853 | -43.063 | -98.747 | -95.438 | -58.298 | -57.898 | -53.272 | -36.446 | 1 | 1 | 1 | 1 | -0.2 | 0.988 | 0.903 | 0.897 | 0.851 | 0.222 | 0.483 | 0.674 | 0.762 | 0.795 | 1 | 1 |
Reseach & Development Expenses
| 27.73 | 35.511 | 20.308 | 33.637 | 13.59 | 18.154 | 33.515 | 60.081 | 103.12 | 85.637 | 43.906 | 28.908 | 13.452 | 9.899 | 9.588 | 12.703 | 8.778 | 3.777 | 4.469 | 3.621 | 1.624 | 5.956 | 4.908 | 3.114 | 2.89 | 2.86 | 1.97 | 0.66 |
General & Administrative Expenses
| 29.71 | 33.353 | 33.399 | 54.259 | 16.283 | 27.015 | 21.499 | 19.808 | 24.903 | 16.949 | 12.364 | 15.675 | 13.335 | 5.463 | 5.799 | 8.906 | 7.171 | 2.273 | 2.005 | 2.845 | 4.059 | 7.463 | 4.759 | 3.682 | 2.54 | 1.77 | 0.88 | 0.7 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 29.71 | 33.353 | 33.399 | 54.259 | 16.283 | 27.015 | 21.499 | 19.808 | 24.903 | 16.949 | 12.364 | 15.675 | 13.335 | 5.463 | 5.799 | 8.906 | 7.171 | 2.273 | 2.005 | 2.845 | 4.059 | 7.463 | 4.759 | 3.682 | 2.54 | 1.77 | 0.88 | 0.7 |
Other Expenses
| 0 | 0.033 | -0.647 | 0 | 0 | 0 | -2.297 | -5.68 | 0 | -18.905 | -10.63 | -11.145 | 0.01 | 0.002 | 0.007 | 0.022 | 0.007 | 0.747 | 0.063 | 0.262 | 1.285 | 2.346 | 0.467 | 0.199 | 0.18 | 0.16 | 0.14 | 0.1 |
Operating Expenses
| 57.44 | 68.864 | 53.707 | 87.896 | 29.873 | 45.169 | 55.014 | 79.889 | 128.023 | 102.597 | 56.282 | 44.597 | 26.797 | 15.364 | 15.394 | 21.631 | 15.956 | 6.797 | 6.537 | 6.728 | 6.968 | 15.765 | 10.133 | 6.995 | 5.61 | 4.79 | 2.99 | 1.46 |
Operating Income
| -55.508 | -67.181 | -52.702 | -86.605 | -27.463 | -41.481 | -54.678 | -79.266 | -126.284 | -101.143 | -57.473 | -43.825 | -26.787 | -15.354 | -15.773 | -21.621 | -15.958 | -5.997 | -6.425 | -6.378 | -6.518 | -15.763 | -10.071 | -6.89 | -5.45 | -4.48 | -2.51 | -1.23 |
Operating Income Ratio
| -28.731 | -39.917 | -52.44 | -67.084 | -11.395 | -100.682 | -162.732 | -127.233 | -72.619 | -69.562 | -71.042 | -56.768 | -2,678.7 | -1,535.4 | -1,577.3 | -2,162.1 | -1,595.8 | -7.496 | -51.815 | -16.354 | -12.321 | -1,751.444 | -77.798 | -44.175 | -25.952 | -11.487 | -5.229 | -5.348 |
Total Other Income Expenses Net
| -7.091 | -37.851 | 231.828 | -443.216 | 7.167 | 5.687 | -18.465 | -0.948 | 11.543 | -34.491 | -10.315 | -23.495 | -6.043 | -12.014 | -9.498 | -0.71 | -5.289 | 4.602 | -3.512 | -2.13 | 0.766 | 2.959 | -869.151 | 0 | -0.16 | -0.24 | -0.05 | 0 |
Income Before Tax
| -62.599 | -105.032 | 179.126 | -529.821 | -20.296 | -35.794 | -73.143 | -80.214 | -114.741 | -135.634 | -65.789 | -67.32 | -32.83 | -27.368 | -25.271 | -22.331 | -21.247 | -1.395 | -9.937 | -8.508 | -5.752 | -12.804 | -10,939.764 | 0 | -5.61 | -4.72 | -2.56 | -1.23 |
Income Before Tax Ratio
| -32.401 | -62.408 | 178.235 | -410.396 | -8.422 | -86.879 | -217.688 | -128.754 | -65.981 | -93.283 | -81.321 | -87.202 | -3,283 | -2,736.8 | -2,527.1 | -2,233.1 | -2,124.7 | -1.744 | -80.137 | -21.815 | -10.873 | -1,422.667 | -84,512.183 | 0 | -26.714 | -12.103 | -5.333 | -5.348 |
Income Tax Expense
| 0 | 31.816 | 4.364 | 8.544 | 3.276 | 15.558 | 3.248 | -1.862 | 4.153 | -17.909 | -9.787 | 2.297 | 6.043 | 12.014 | 9.887 | 0.71 | 0.01 | -4.602 | 0 | 2.13 | -0.766 | -2.959 | -868.282 | 5.89 | -0.32 | -0.47 | 0 | 0 |
Net Income
| -62.599 | -136.848 | 179.126 | -538.365 | -23.572 | -35.794 | -73.143 | -80.214 | -114.741 | -135.634 | -65.789 | -67.32 | -32.83 | -27.368 | -25.271 | -22.331 | -21.257 | -1.395 | -9.937 | -8.508 | -5.752 | -12.804 | -10.94 | -12.779 | -5.61 | -4.72 | -2.56 | -1.23 |
Net Income Ratio
| -32.401 | -81.312 | 178.235 | -417.014 | -9.781 | -86.879 | -217.688 | -128.754 | -65.981 | -93.283 | -81.321 | -87.202 | -3,283 | -2,736.8 | -2,527.1 | -2,233.1 | -2,125.7 | -1.744 | -80.137 | -21.815 | -10.873 | -1,422.667 | -84.512 | -81.938 | -26.714 | -12.103 | -5.333 | -5.348 |
EPS
| -0.058 | -0.13 | 0.21 | -0.74 | -0.042 | -0.081 | -0.3 | -0.72 | -1.48 | -2.29 | -2 | -5.72 | -5.58 | -6.53 | -8.43 | -8.42 | -13.93 | -6.27 | -125.07 | -107.31 | -73.01 | -181.71 | -997.97 | -1,474.3 | -561 | -472 | -256 | -123 |
EPS Diluted
| -0.058 | -0.13 | -0.06 | -0.74 | -0.042 | -0.081 | -0.3 | -0.72 | -1.48 | -2.29 | -2 | -5.72 | -5.58 | -6.53 | -8.43 | -8.42 | -13.93 | -6.27 | -125.07 | -107.31 | -73.01 | -181.71 | -997.97 | -1,474.3 | -561 | -472 | -256 | -123 |
EBITDA
| -55.508 | -97.416 | 184.723 | -520.852 | -17.816 | -24.623 | -67.159 | -76.207 | -110.532 | -134.627 | -64.904 | -51.822 | -25.172 | -15.352 | -15.766 | -21.599 | -10.189 | -5.96 | -3.454 | -4.687 | -6.269 | -15.17 | -8.923 | -1.303 | -5.57 | -4.79 | -2.61 | -1.23 |
EBITDA Ratio
| -28.731 | -39.007 | -52.5 | -66.754 | -11.395 | -105.5 | -168.262 | -136.047 | -72.587 | -82.556 | -81.695 | -71.187 | -2,838.2 | -1,073.3 | -937.1 | -2,123.9 | -1,018.9 | -13.886 | -27.855 | -10.741 | -11.355 | -1,806.333 | -68.931 | -8.357 | -26.524 | -12.282 | -5.438 | -5.348 |